PAUL SCHIMMEL Insider Trading $LIFE aTYR PHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL SCHIMMEL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL SCHIMMEL. PAUL SCHIMMEL is Director in ALKERMES INC ($ALKS) and Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in aTYR PHARMA INC ($LIFE) and Director in Tocagen Inc ($TOCA).
PAUL SCHIMMEL in aTYR PHARMA INC
Trading Symbol: LIFEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PAUL SCHIMMEL: Director
Holdings: 429,143 shares
Current Value: $1,459,086
Latest Transaction: Apr 29 2021
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PAUL SCHIMMEL in aTYR PHARMA INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALKS, ALNY, LIFE, TOCA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2021 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | A | 4.21 | 1,428 | 6,012 | 1,428 | |
May 22 2020 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Sell | S | 3.64 | 8,447 | 30,739 | 429,143 | 437.6 K to 429.1 K (-1.93 %) |
May 08 2020 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | A | 3.65 | 1,428 | 5,212 | 1,428 | |
Feb 11 2020 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 4.25 | 254,000 | 1,079,500 | 437,590 | 183.6 K to 437.6 K (+138.35 %) |
May 10 2019 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | A | 0.58 | 20,000 | 11,668 | 20,000 | |
Apr 16 2019 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Grant | A | 0.54 | 1,848,428 | 1,000,000 | 2,570,242 | 721.8 K to 2.6 M (+256.08 %) |
Nov 28 2018 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 0.54 | 147,225 | 79,796 | 882,302 | 735.1 K to 882.3 K (+20.03 %) |
Sep 05 2018 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 0.76 | 20,749 | 15,709 | 735,077 | 714.3 K to 735.1 K (+2.90 %) |
Sep 05 2018 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 0.72 | 22,000 | 15,752 | 714,328 | 692.3 K to 714.3 K (+3.18 %) |
Aug 31 2018 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 0.76 | 89,275 | 67,483 | 692,328 | 603.1 K to 692.3 K (+14.80 %) |
Aug 31 2018 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 0.72 | 75,136 | 54,090 | 603,053 | 527.9 K to 603.1 K (+14.23 %) |
May 21 2018 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 1.00 | 150,000 | 149,445 | 527,917 | 377.9 K to 527.9 K (+39.69 %) |
May 17 2018 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | A | 1.35 | 20,000 | 27,000 | 20,000 | |
Sep 05 2017 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | P | 4.64 | 35,376 | 164,145 | 35,376 | |
Sep 05 2017 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 2.65 | 94,336 | 249,990 | 377,917 | 283.6 K to 377.9 K (+33.27 %) |
May 11 2017 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | A | 3.15 | 20,000 | 63,000 | 20,000 | |
Dec 22 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 2.28 | 10,000 | 22,818 | 721,814 | 711.8 K to 721.8 K (+1.40 %) |
Dec 22 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 2.27 | 15,000 | 34,110 | 711,814 | 696.8 K to 711.8 K (+2.15 %) |
Dec 19 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 2.40 | 10,000 | 23,973 | 696,814 | 686.8 K to 696.8 K (+1.46 %) |
Dec 19 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 2.50 | 40,000 | 99,912 | 686,814 | 646.8 K to 686.8 K (+6.18 %) |
Dec 19 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Gift | G | 0.00 | 12,572 | 0 | 646,814 | 634.2 K to 646.8 K (+1.98 %) |
Dec 19 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Gift | G | 0.00 | 12,572 | 0 | 40,440 | 53 K to 40.4 K (-23.72 %) |
May 26 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | A | 3.33 | 18,000 | 59,940 | 18,000 | |
Apr 07 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.20 | 25,000 | 80,000 | 62,572 | 37.6 K to 62.6 K (+66.54 %) |
Apr 06 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.52 | 25,000 | 88,118 | 37,572 | 12.6 K to 37.6 K (+198.85 %) |
Apr 15 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 4.14 | 32,600 | 135,075 | 53,012 | 20.4 K to 53 K (+159.71 %) |
Apr 15 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 4.22 | 33,619 | 141,859 | 283,581 | 250 K to 283.6 K (+13.45 %) |
Apr 14 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.85 | 9,835 | 37,865 | 249,962 | 240.1 K to 250 K (+4.10 %) |
Apr 13 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.70 | 6,546 | 24,220 | 240,127 | 233.6 K to 240.1 K (+2.80 %) |
Apr 13 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.75 | 2,581 | 9,682 | 20,412 | 17.8 K to 20.4 K (+14.47 %) |
Apr 12 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.45 | 5,300 | 18,275 | 220,231 | 214.9 K to 220.2 K (+2.47 %) |
Apr 12 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.59 | 27,359 | 98,260 | 214,931 | 187.6 K to 214.9 K (+14.59 %) |
Apr 11 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.22 | 85,000 | 273,649 | 187,572 | 102.6 K to 187.6 K (+82.87 %) |
Apr 08 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.19 | 40,000 | 127,584 | 102,572 | 62.6 K to 102.6 K (+63.93 %) |
Jan 29 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | A | 6.14 | 19,428 | 119,288 | 19,428 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Gift | G | 0.00 | 11,925 | 0 | 634,242 | 646.2 K to 634.2 K (-1.85 %) |
Jul 10 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | A | 14.96 | 6,286 | 94,039 | 6,286 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 446,827 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 15,031 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 558,508 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 1,440,058 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 1,200,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 525,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 248,024 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | C | 0.00 | 46,152 | 0 | 646,167 | 600 K to 646.2 K (+7.69 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | C | 0.00 | 470,020 | 0 | 600,015 | 130 K to 600 K (+361.57 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | C | 0.00 | 31,181 | 0 | 31,181 | 0 to 31.2 K |
Page: 1